Nicotine, as a novel tolerogenic adjuvant, enhances the efficacy of immunotherapy in a mouse model of allergic asthma

An increasing trend in the incidence of allergic diseases including asthma and related morbidity and mortality is observed worldwide during the last decades. Allergen-specific immunotherapy is suggested for the treatment of some allergic diseases; nevertheless, there is always a menace of uncommon,...

Descripción completa

Detalles Bibliográficos
Autores principales: Mazloomi, Ebrahim, Ilkhanizadeh, Behrooz, Zare, Ahad, Mohammadzadeh, Adel, Delirezh, Nowruz, Shahabi, Shahram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714111/
https://www.ncbi.nlm.nih.gov/pubmed/31516507
http://dx.doi.org/10.4103/1735-5362.263555

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714111/
https://www.ncbi.nlm.nih.gov/pubmed/31516507
http://dx.doi.org/10.4103/1735-5362.263555

Ejemplares similares